Clinical Study

Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients

Table 1

Cohorts of primary glioblastoma patients who were positive or negative for glioma cancer stem cells (gCSCs) [6].

PatientsgCSC candidatesAge (years)SexPodoplaninCD133Nestin

gCSC positivegCSC031557F++
gCSC042644F++
gCSC052072F++
gCSC071355F
gCSC050439M+++
gCSC112048F+++
gCSC050364M+++
gCSC011453M++
gCSC021351F++
gCSC022868M+++
gCSC030861M+++
gCSC092411M+++
gCSC051049F+++
gCSC062761M+++
gCSC052034M+++

gCSC negativegCSC040638F
gCSC0824171F
gCSC100559F
gCSC112463F
gCSC022628M
gCSC030959M
gCSC080360F
gCSC0824265F
gCSC062066F
gCSC092846M
gCSC110882M
gCSC021960M
gCSC052866F
gCSC061049M
gCSC070263M
gCSC070924M
gCSC081657M
gCSC082262F
gCSC111857F
gCSC121844M
gCSC010268M
gCSC010657F
gCSC052960F
gCSC110257M

gCSC: glioma cancer stem cell; M: male; F: female; +: positive for expression as assessed using immunocytochemical methods [6]; −: negative for expression, as assessed using immunocytochemical methods [6].